Same and Stool softener needs - a phase IV clinical study of FDA data
Summary:
We study 337,943 people who take Same (same) or have Stool softener needs. No report of Stool softener needs is found in people who take Same.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Same?
Same has active ingredients of same. It is often used in depression. eHealthMe is studying from 65 Same users. Check the latest studies of Same.
What is Stool Softener Needs?
Stool softener needs is found to be associated with 3,891 drugs and 4,762 conditions by eHealthMe. Check the latest studies of Stool softener needs.
No report is found.
Do you take Same and have Stool softener needs?
- Check whether Stool softener needs is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Same:
- Same (65 reports)
Stool softener needs treatments and more:
- Stool softener needs (337,878 reports)
How severe was Stool softener needs and when was it recovered:
Expand to all the drugs that have ingredients of same:
Browse all side effects of Same:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Stool softener needs:
Browse all the conditions that are associated with Stool softener needs:
How the study uses the data?
The study uses data from the FDA. It is based on same (the active ingredients of Same) and Same (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Humatrope and Abilify - now
- Could Flonase cause Lymphadenopathy Mediastinal? - a second ago
- Could Latuda cause Maternal Exposure During Pregnancy? - a second ago
- Tacrolimus and Sun-Induced Skin Changes - Keratosis for Women aged 40-49 - 2 seconds ago
- Tacrolimus and Solar Keratosis for Women aged 40-49 - 3 seconds ago
- Tacrolimus and Keratosis - Actinic (Solar) for Women aged 40-49 - 3 seconds ago
- Tacrolimus and Actinic Keratosis for Women aged 40-49 - 4 seconds ago
- Xeljanz and Prozac drug interactions for women aged 40-49 - 4 seconds ago
- Could Effexor cause Cheilitis? - 5 seconds ago
- Rebif and Cellulitis Aggravated for Women aged 30-39 - 9 seconds ago